COVID-19: The Course, Vaccination and Immune Response in People with Multiple Sclerosis: Systematic Review
When the Coronavirus Disease 2019 (COVID-19) appeared, it was unknown what impact it would have on the condition of patients with autoimmunological disorders. Attention was focused on the course of infection in patients suffering from multiple sclerosis (MS), specially treated with disease-modifying...
Main Authors: | Marcin Bazylewicz, Monika Gudowska-Sawczuk, Barbara Mroczko, Jan Kochanowicz, Alina Kułakowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/11/9231 |
Similar Items
-
Kappa Free Light Chains and IgG Combined in a Novel Algorithm for the Detection of Multiple Sclerosis
by: Monika Gudowska-Sawczuk, et al.
Published: (2020-05-01) -
Analysis of the Presence and Levels of IgG Antibodies Directed against the S1 Protein Receptor Binding Domain and the N Protein of SARS-CoV-2 in Patients with Multiple Sclerosis Treated with Immunomodulatory Therapies
by: Joanna Kulikowska, et al.
Published: (2024-02-01) -
Case report: First manifestation of multiple sclerosis temporally correlated with COVID-19 vaccination
by: Agata Czarnowska, et al.
Published: (2023-02-01) -
COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece
by: Christos Bakirtzis, et al.
Published: (2023-08-01) -
Safety, immunogenicity, efficacy, and acceptability of COVID-19 vaccination in people with multiple sclerosis: a narrative review
by: Fioravante Capone, et al.
Published: (2023-01-01)